Notice: Grant of Authority For Subzone Status, Banner Pharmacaps, Inc.

Federal Register: September 18, 2008 (Volume 73, Number 182)     
                  Page 54138

Agency:  DEPARTMENT OF COMMERCE
         Foreign-Trade Zones Board


Banner Pharmacaps, Inc.
(Prescription Pharmaceuticals and Soft Gelatin Capsules)
High Point, North Carolina

    Pursuant to its authority under the Foreign-Trade Zones Act of 
June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade 
Zones Board (the Board) adopts the following Order:
    WHEREAS, the Foreign-Trade Zones Act provides for `` . . . the 
establishment . . . of foreign-trade zones in ports of entry of the 
United States, to expedite and encourage foreign commerce, and for 
other purposes,'' and authorizes the Foreign-Trade Zones Board to grant 
to qualified corporations the privilege of establishing foreign-trade 
zones in or adjacent to U.S. Customs and Border Protection ports of 
entry;
    WHEREAS, the Board's regulations (15 CFR Part 400) provide for the 
establishment of special-purpose subzones when existing zone facilities 
cannot serve the specific use involved, and when the activity results 
in a significant public benefit and is in the public interest;
    WHEREAS, the Piedmont Triad Partnership, grantee of FTZ 230, has 
made application to the Board for authority to establish special-
purpose subzone status at the pharmaceutical manufacturing plant of 
Banner Pharmacaps, Inc., located in High Point, North Carolina (FTZ 
Docket 8-2008, filed 2/12/08);
    WHEREAS, notice inviting public comment has been given in the 
Federal Register (73 FR 10421, 2/27/08); and,
    WHEREAS, the Board adopts the findings and recommendations of the 
examiner's report, and finds that the requirements of the FTZ Act and 
the Board's regulations are satisfied, and that approval of the 
application is in the public interest;
    NOW, THEREFORE, the Board hereby grants authority for subzone 
status for activity related to certain prescription pharmaceutical 
product and soft gelatin capsule manufacturing at the Banner 
Pharmacaps, Inc., facility located in High Point, North Carolina 
(Subzone 230C), as described in the application and Federal Register 
notice, and subject to the FTZ Act and the Board's regulations, 
including Section 400.28.
    Signed at Washington, DC, this 2\nd\ day of September 2008.

David M. Spooner,
Assistant Secretary of Commerce for Import Administration.
Alternate Chairman Foreign-Trade Zones Board.
    ATTEST:
Andrew McGilvray,
Executive Secretary.
[FR Doc. E8-21847 Filed 9-17-08; 8:45 am]

BILLING CODE 3510-DS-S